IDH1 and glioblastoma: In this sense, a technique comparison study comprising 62 glioblastoma samples to detect IDH1 mutations by Sanger direct sequencing, ddPCR or quantitative real-time PCR (qRT-PCR) showed that ddPCR was more sensitive method to screen for IDH1 mutations [57].